Morgan, S G, Cunningham, C and Law, M R (2012) Drug development: innovation or imitation deficit? British Medical Journal, 345 (e5880). ISSN 0959-8138
Official URL: http://www.bmj.com/content/345/bmj.e5880
Abstract
Light and Lexchin argue that the pharmaceutical innovation crisis is a myth.1 Although they correctly diagnose the issue, the drug approval data provided tell only half of the story. To shed more light on drug development trends, we classified US Food and Drug Administration approvals of new drugs (therapeutic new molecular entities) into one of three mutually exclusive categories: first-of-kind drugs to be approved within chemical or …
More Details
Item Type: | Article |
---|---|
Subject Areas: | Strategy and Entrepreneurship |
Date Deposited: | 31 Aug 2017 15:41 |
Subjects: |
Research and development Pharmaceutical industry |
Last Modified: | 06 Oct 2024 01:53 |
URI: | https://lbsresearch.london.edu/id/eprint/871 |